Search

everythinglearnresearchcommunity

for

Search:↓

TP0427736 may help treat hair loss by blocking a specific protein and promoting hair growth.

Diphencyprone (DCP) is an effective treatment for severe alopecia areata and resistant warts, with some risks.

New treatments for non-small cell lung cancer are being tested, with some already in use, focusing on immune response and targeting cancer cells, but side effects vary.

Activating c-Myc in skin causes rapid cell growth and changes, but these effects are reversible.

Septin4 helps kill colon cancer cells by working with the protein BAX.

JAK inhibitors helped treat hair loss in two people with Down syndrome.

A KLK5 inhibitor effectively improved skin symptoms in a mouse model of Netherton Syndrome.

Deuruxolitinib is approved to treat severe alopecia areata in adults.

High ODC and low K1 and K10 may indicate early skin tumors in mice.

Mouse skin cancer progression involves a unique group of cells marked by ABCG2 and MTS24.

Excessive eyelash growth from erlotinib may indicate positive tumor response and help treat madarosis.

Ritlecitinib is a new treatment for severe hair loss in people 12 and older.

Prostaglandins and the enzyme AKR1C3 could play a role in skin cancer and hair loss, and further research is needed to understand these mechanisms.

Certain cancer drugs can cause skin issues like rashes and itching.

Topical calcitriol (BPM31543) is safe for preventing hair loss from chemotherapy and shows some effectiveness.

Chemotherapy with carboplatin-paclitaxel causes hair loss in all patients.

Dual-targeting therapies like Janus kinase inhibitors may treat both alopecia areata and other immune diseases.

Janus kinase inhibitors can help children with alopecia areata regrow hair but may have some risks.

Imatinib mesylate can cause skin lightening, especially in Chinese patients, due to its effect on pigment production.

Baricitinib effectively treats certain skin conditions but may have serious side effects.

Doxycycline helps prevent skin issues from erlotinib in lung cancer patients.

Scientists made new substances that can block an enzyme linked to prostate issues and hair loss, with potential for creating a new treatment.

CAP7.1 is generally safe at 200 mg/m²/day, but can cause fatigue, nausea, hair loss, fever, and blood-related issues.

Drugs that block GSK-3 show promise for treating various diseases.

INTASYL is a promising, adaptable RNAi technology for treating skin cancers.

Ritlecitinib is effective and safe for treating severe alopecia areata in people aged 12 and older.

Ceramide Synthase 4 is essential for normal hair growth and preventing hair loss.

VDC-1101 shows potential as a treatment for canine cutaneous T-cell lymphoma.

Researchers found that hair follicle stem cells can become squamous cell carcinoma due to Ras activation, which could lead to new treatments.

JAK inhibitors can be safely used in alopecia areata patients with latent hepatitis B or tuberculosis, with proper monitoring.